4.6 Article

Long-term neurological complications in COVID-19 survivors: study protocol of a prospective cohort study (NeurodegCoV-19)

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis

Lauren L. O'Mahoney et al.

Summary: This study systematically synthesized global evidence on the prevalence of persistent symptoms in a general post COVID-19 population. The findings show that regardless of hospitalization status, at least 45% of COVID-19 survivors experience unresolved symptoms for about 4 months. The current understanding of Long Covid is limited by heterogeneous study design, follow-up durations, and measurement methods, hindering effective treatment and management strategies.

ECLINICALMEDICINE (2023)

Editorial Material Pharmacology & Pharmacy

COVID-19 Neurologic Manifestations

[Anonymous]

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Article Infectious Diseases

SARS-CoV-2 seroprevalence in Portugal following the third epidemic wave: results of the second National Serological Survey (ISN2COVID-19)

Irina Kislaya et al.

Summary: This study aimed to assess the extent of SARS-CoV-2 infection and vaccine-induced immune response in the Portuguese population. The results showed that the post-infection SARS-CoV-2 seroprevalence was higher than the PCR-based cumulative incidence after the third wave of the epidemic, and children had a higher seroprevalence compared to other age groups.

INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Parkinsonism: An emerging post COVID sequelae

Abhijith Rajaram Rao et al.

Summary: COVID-19 can lead to parkinsonism in older adults, age 60 years and above, and they respond well to levodopa-carbidopa treatment.

IDCASES (2022)

Review Neurosciences

The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2

Lisa Bauer et al.

Summary: This article provides an overview of neurological complications associated with SARS-CoV-2 infection and discusses their pathogenesis. It outlines the distinctions between neuroinvasiveness, neurotropism, and neurovirulence, and explores the advantages and limitations of different experimental models in advancing the field.

TRENDS IN NEUROSCIENCES (2022)

Article Clinical Neurology

One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China A Longitudinal Cohort Study

Yu-Hui Liu et al.

Summary: This cohort study found that COVID-19 survivors have an increased risk of cognitive decline, highlighting the importance of immediate measures to address this challenge.

JAMA NEUROLOGY (2022)

Review Clinical Neurology

Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far

Iro Boura et al.

Summary: There is currently no clear evidence to indicate a direct association between the Covid-19 pandemic and a wave of parkinsonism. However, vigilance is necessary.

MOVEMENT DISORDERS CLINICAL PRACTICE (2022)

Article Environmental Sciences

Fatigue and Cognitive Dysfunction Are Associated with Occupational Status in Post-COVID Syndrome

Cristina Delgado-Alonso et al.

Summary: Post-COVID syndrome affects work capacity, with fatigue and cognitive issues being the most frequent symptoms associated with loss of work capacity.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2022)

Article Neurosciences

In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants

Lisa Bauer et al.

Summary: The Delta and Omicron BA.1 variants of SARS-CoV-2 exhibit reduced neuroinvasiveness and neurovirulence compared to the ancestral strain D614G, as shown in in vitro and in vivo experiments.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Article Medicine, General & Internal

Seroprevalence of SARS-CoV-2 Infection in Portugal in May-July 2020: Results of the First National Serological Survey (ISNCOVID-19)

Irina Kislaya et al.

Summary: The study aimed to estimate and describe the prevalence of SARS-CoV-2 specific antibodies in Portugal from May to July 2020. The overall seroprevalence was 2.9%, with higher rates in males and individuals with secondary education. Age group and region did not show statistically significant differences in seroprevalence.

ACTA MEDICA PORTUGUESA (2021)

Article Clinical Neurology

Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort

Oscar H. Del Brutto et al.

Summary: This study provides evidence of cognitive decline among individuals with mild symptomatic SARS-CoV-2 infection. The pathogenesis of this complication remains unknown. Seropositive individuals were found to have a higher risk of cognitive decline compared to seronegative individuals.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Letter Clinical Neurology

Parkinson's disease after COVID-19

Karim Makhoul et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)

Article Oncology

Trajectories of cognitive performance over five years in a prospective cohort of patients with breast cancer (NEON-BC)

Natalia Araujo et al.

Summary: A study of breast cancer patients over five years identified two trajectories of cognitive performance, with four groups classified based on baseline MoCA scores. Assessing cognitive performance before treatment and after one year can help predict long-term cognitive decline.

BREAST (2021)

Article Medicine, General & Internal

Risk Categories in COVID-19 Based on Degrees of Inflammation: Data on More Than 17,000 Patients from the Spanish SEMI-COVID-19 Registry

Manuel Rubio-Rivas et al.

Summary: This study identifies three risk categories for COVID-19 patients based on lymphopenia and inflammatory parameters, with older male patients with various comorbidities at higher risk and requiring more intensive treatments.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Clinical Neurology

Frequency of Neurologic Manifestations in COVID-19 A Systematic Review and Meta-analysis

Shubham Misra et al.

Summary: Up to one-third of patients with COVID-19 experienced at least one neurologic manifestation in this review. 1 in 50 patients experienced stroke. In patients over 60 years of age, more than one-third had acute confusion/delirium; the presence of neurologic manifestations in this group was associated with nearly a doubling of mortality.

NEUROLOGY (2021)

Article Psychiatry

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records

Maxime Taquet et al.

Summary: Our study provides evidence of significant neurological and psychiatric morbidity in the 6 months following COVID-19 infection. The risks were highest in patients with severe COVID-19. This information could assist in service planning and research priority identification.

LANCET PSYCHIATRY (2021)

Article Clinical Neurology

Cognitive and physical markers of prodromal dementia: A 12-year-long population study

Giulia Grande et al.

ALZHEIMERS & DEMENTIA (2020)

Article Infectious Diseases

A minimal common outcome measure set for COVID-19 clinical research

J. C. Marshall et al.

LANCET INFECTIOUS DISEASES (2020)

Article Medicine, General & Internal

Cerebral Micro-Structural Changes in COVID-19 Patients - An MRI-based 3-month Follow-up Study

Yiping Lu et al.

ECLINICALMEDICINE (2020)

Review Geriatrics & Gerontology

Measuring gait speed to better identify prodromal dementia

Giulia Grande et al.

EXPERIMENTAL GERONTOLOGY (2019)

Review Geriatrics & Gerontology

Poor Gait Performance and Prediction of Dementia: Results From a Meta-Analysis

Olivier Beauchet et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2016)

Review Clinical Neurology

Advances in markers of prodromal Parkinson disease

Ronald B. Postuma et al.

NATURE REVIEWS NEUROLOGY (2016)

Article Multidisciplinary Sciences

Development of a self-administered web-based test for longitudinal cognitive assessment

Luis Ruano et al.

SCIENTIFIC REPORTS (2016)

Article Psychology, Clinical

The Clock Drawing Test: Portuguese Norms, by Age and Education, for Three Different Scoring Systems

Isabel Santana et al.

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2013)

Article Psychology, Clinical

Trail Making Test: Regression-based Norms for the Portuguese Population

Sara Cavaco et al.

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2013)

Article Psychology, Clinical

Semantic Fluency and Phonemic Fluency: Regression-based Norms for the Portuguese Population

Sara Cavaco et al.

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2013)

Article Psychology, Clinical

The Estimation of Premorbid Intelligence Levels among Portuguese Speakers: The Irregular Word Reading Test (TeLPI)

Lara Alves et al.

ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2012)

Review Clinical Neurology

Identifying prodromal Parkinson's disease: Pre-Motor disorders in Parkinson's disease

Ronald B. Postuma et al.

MOVEMENT DISORDERS (2012)

Review Clinical Neurology

Screening questionnaires for parkinsonism: A systematic review

Nabila Dahodwala et al.

PARKINSONISM & RELATED DISORDERS (2012)

Article Psychology, Clinical

Montreal Cognitive Assessment (MoCA): Normative study for the Portuguese population

Sandra Freitas et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2011)

Article Psychology, Applied

The Portuguese Version of the Beck Depression Inventory-II (BDI-II) Preliminary Psychometric Data with Two Nonclinical Samples

Rui C. Campos et al.

EUROPEAN JOURNAL OF PSYCHOLOGICAL ASSESSMENT (2011)

Article Anesthesiology

STOP questionnaire - A tool to screen patients for obstructive sleep apnea

Frances Chung et al.

ANESTHESIOLOGY (2008)

Article Psychology, Clinical

Can an 18-point clock-drawing scoring system predict dementia in elderly individuals with mild cognitive impairment?

Lennie Babins et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2008)

Article Geriatrics & Gerontology

The montreal cognitive assessment, MoCA:: A brief screening tool for mild cognitive impairment

ZS Nasreddine et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2005)

Review Psychiatry

The validity of the Hospital Anxiety and Depression Scale - An updated literature review

I Bjelland et al.

JOURNAL OF PSYCHOSOMATIC RESEARCH (2002)